TVARDI THERAPEUTICS, INC. Restructuring Reserve, Noncurrent
TVARDI THERAPEUTICS, INC. (TVRD) had Restructuring Reserve, Noncurrent of $50.00 thousand as of 2024-12-31, per its 10-K filed 2025-03-11.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:RestructuringReserveNoncurrent · last filed 2025-03-11
- 2024-12-31: Restructuring Reserve, Noncurrent $50.00K.
- 2024-09-30: Restructuring Reserve, Noncurrent $286.00K.
- 2024-06-30: Restructuring Reserve, Noncurrent $2.98M.
- 2024-03-31: Restructuring Reserve, Noncurrent $699.00K.
| Period end | Restructuring Reserve, Noncurrent |
|---|---|
| 2024-12-31 | $50.00K 10-K · filed 2025-03-11 |
| 2024-09-30 | $286.00K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $2.98M 10-Q · filed 2024-11-14 |
| 2024-03-31 | $699.00K 10-Q · filed 2024-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |